VASO Corp
VASO · OTCMCIK 839087fmd_0Q6CWD2D6AAXMNRN4TFR98DTM7Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jun 01, 2009 to Jun 30, 2026, 68 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 73 | 73 | 74 | 76 | 70 | 76 | 79 | 81 | 87 | 89 |
| Cost of revenue | 31 | 32 | 33 | 33 | 31 | 32 | 31 | 30 | 35 | 34 |
| Net investment income | – | – | – | – | 0 | 6 | – | – | – | – |
| Gross profit | 42 | 41 | 41 | 42 | 39 | 43 | 48 | 51 | 52 | 55 |
| Provision for credit losses | 0 | 0 | – | – | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | – | – | (0) | (0) | (0) | (0) |
| Research and development | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 39 | 44 | 44 | 41 | 37 | 39 | 41 | 45 | 49 | 52 |
| Total operating expenses | 40 | 45 | 45 | 42 | 38 | 40 | 41 | 46 | 52 | 58 |
| Operating income | 2 | (4) | (4) | 1 | 1 | 3 | 6 | 4 | 0 | (3) |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | (1) | (0) | (1) | (0) | 3 | 0 | 1 | 1 | 2 |
| Income before taxes | 1 | (4) | (4) | (0) | 0 | 6 | 7 | 5 | 1 | (1) |
| Income tax expense | 0 | 0 | (0) | 0 | 0 | 0 | (5) | 0 | 0 | (3) |
| Net income from continuing operations | 1 | (5) | (4) | (0) | 0 | 6 | 11 | 5 | 1 | 2 |
| Net income | 1 | (5) | (4) | (0) | 0 | 6 | 11 | 5 | 1 | 2 |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |